Rubicon Research Quarterly Results for Trading Insights

RUBICON • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹54 Cr
QSept 2025
Quarterly Results

Rubicon Research Quarterly Results Key Highlights

  • Revenue of ₹413 Cr in Sept 2025 (+15.4% vs Mar 2025, +38.1% vs Sept 2024)
  • Net Profit of ₹54 Cr in Sept 2025 (+50.0% vs Mar 2025, +54.3% vs Sept 2024)
  • EBITDA of ₹95 Cr in Sept 2025 (+30.1% vs Mar 2025)
  • Operating Margin of 23.0% in Sept 2025 (+3.0pp vs Mar 2025)
  • Earnings Per Share of ₹3.49 in Sept 2025 (+48.5% vs Mar 2025)

Rubicon Research Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 413 358 353 479 299 15.4% 38.1%
Net Profit (₹ Cr) 54 36 43 73 35 - -
EBITDA (₹ Cr) 95 73 80 112 64 - -
EPS (₹) 3.49 2.35 2.81 4.46 2.27 - -
Operating Margin (%) 23.0% 20.0% 22.0% 23.0% 21.0% - -

Rubicon Research Share Price Trend Around Quarterly Results

Visualize Rubicon Research's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Rubicon Research

Additional stock information and data for RUBICON

RUBICON company profile
RUBICON price earnings ratio
RUBICON yearly price range

Profitability Ratios

Profit Margin 13.1%
EBITDA Margin 23.0%
Operating Margin 23.0%
ROE (Annual) 39.9%

Balance Sheet Highlights

Total Assets ₹1,451 Cr
Total Equity ₹541 Cr
Current Assets ₹1,063 Cr
Current Liabilities ₹124 Cr

Cash Flow Analysis

Operating Cash Flow ₹159 Cr
Investing Cash Flow ₹-65 Cr
Financing Cash Flow ₹-40 Cr
Net Cash Flow ₹54 Cr

Current Market Data

Current Price ₹774.85
Exchange NSE
Last Updated Apr 02, 2026

Revenue Trend (₹ Cr)

Dec 2025 479
Jun 2025 353
Mar 2025 358
Sept 2025 413

Net Profit Trend (₹ Cr)

Dec 2025 73
Jun 2025 43
Mar 2025 36
Sept 2025 54

Operating Margin Trend (%)

Dec 2025 23.0%
Jun 2025 22.0%
Mar 2025 20.0%
Sept 2025 23.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Rubicon Research quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹430,344.72 Cr 1693.6 14,875 3,125 +10.8% - 21.0% 130.3
Divis Laboratories
Sept 2025 		₹159,214.78 Cr 5856.5 2,860 689 +7.1% - 24.1% 225.5
Torrent Pharmaceuti…
Sept 2025 		₹144,367.29 Cr 3987.2 3,219 591 +11.3% - 18.4% 227.3
Lupin
Sept 2025 		₹107,238.09 Cr 2274.5 6,921 1,485 +23.2% - 21.5% 70.3
Dr Reddys Laborator…
Sept 2025 		₹106,974.57 Cr 1217.3 9,135 1,337 +1.1% - 14.6% 75.2
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores